Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

mobetterstocks 3 posts  |  Last Activity: Jun 20, 2015 2:52 PM Member since: Oct 18, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    These folks sold Solvaldi to GILD

    by la_cossack May 7, 2015 12:41 PM
    mobetterstocks mobetterstocks Jun 20, 2015 2:52 PM Flag

    What TKMR has is the first round of second-generation cyclophilin inhibitors -NVP018 which
    have the potential for therapeutic application in a number of
    areas, in particular chronic viral infection. NVPO18 has a high po-
    tency, a high barrier to resistance and shows activity on multiple steps of the
    viral life cycle- plus it hs oral bioavailability. I have noted
    recent publications suggesting that NVPO18 might
    also have additional impact on interferon regulatory factors,
    which have long been implicated in the escape of certain viruses,
    such as HCV and HIV, from the immune system.

    While cyclophilin inhibitors like NVPO18 do not
    exhibit inhibition of all viruses, these "natural products" have been shown to have
    activity against a wide variety of both RNA viruses including corona-
    viruses, HIV, and HCV). Also against various DNA viruses like human CMV, HBV and varicella zoster virus.

    TKMR has an agent that may lead to a big step forward in the treatment of viral illnesses.

  • mobetterstocks by mobetterstocks Jun 8, 2015 8:56 PM Flag

    As a psychiatrist I am waiting for this medication - many recent advances in understanding the role of serotonin have led to more rational drug design approaches to psychosis in PD- these are able to deliver a novel pharmacological treatment with recently proven efficacy in clinical trials of people with PD and psychosis. Pimavanserin represents an important addition to treatment

  • mobetterstocks by mobetterstocks Jun 1, 2015 5:09 PM Flag

    Surgical cytoreduction restores the antitumor efficacy of a Listeria monocytogenes vaccine in malignant pleural mesothelioma

VRTX
134.05+0.30(+0.22%)Aug 28 4:00 PMEDT